Patient Registries and Cohort Studies

Patient Registries and Cohort Studies

An increased desire to transition from studies designed to meet a single purpose, to reusable data infrastructures that fulfill multiple purposes, has led to a rise in disease and product registries. The availability of electronic health record (EHR) data, and their potential to greatly reduce costs and increase clinical data granularity, has further increased the popularity of these registries in recent years.
Get In Touch
Patient Registries and Cohort Studies Research

Registries help with understand the natural history of a disease, influence the formation of clinical programs, and aid in real-world safety and effectiveness.

In the early development phase, there is increasing reliance on registries to help understand the natural history of a disease and influence clinical programs. In the post-approval stage, registries are being leveraged to measure real-world safety and effectiveness, as well as to uncover new opportunities not evaluated during clinical trials. 

What do you get with Patient Registries and Cohort Studies?

Wealth of data and derived outcomes

Registries can impact diverse stakeholders and have become more widely accepted real-world data (RWD) by regulatory authorities.

Highly validated approach
 

We collect information about disease and treatment patterns that regulatory authorities have come to accept more widely as real-world data (RWD).

Powerful data infrastructure for life sciences research
 

Electronic health record (EHR) data, patient-reported data, and other information from specialized laboratory, imaging and genetic testing, are integrated into robust registries.

Flexibility to meet varied needs
 

Registries can be built using primary data collection methods and/or leveraging existing data.

Our expertise

We can build disease registries to describe the natural history of a disease from patients suffering from, or at risk of, an illness. Product registries will include patients exposed to a particular treatment or device of interest. They often fulfill post-marketing authorization requirements that focus on assessing safety or harm. 

We share your objectives
 

Our overall goal is to improve health outcomes by adding deeper clarity to research and by allowing physicians to focus on quality of care.

Client Results

Natural history

Understand the progression of disease while identifying potential subpopulations and endpoints which matter.

Predict outcomes

Determine with confidence, patient characteristics and treatment patterns which drive better health outcomes.

Complex viewpoints

Understand what impacts clinical, humanistic and economic burden.

Clinical trial data

Measure compound effectiveness and safety as seen in clinical trials in real world populations.

Long-term view

Ascertain long-term treatment outcomes and see all possibilities clearly.